Humacyte, Inc. (HUMA)
1.02
+0.10
(+11.21%)
USD |
NASDAQ |
May 21, 16:00
1.02
0.00 (0.00%)
After-Hours: 17:13
Humacyte Total Assets (Quarterly) : 110.56M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Altimmune, Inc. | 335.63M |
| Vertex Pharmaceuticals, Inc. | 26.48B |
| PDS Biotechnology Corp. | 24.66M |
| Bolt Biotherapeutics, Inc. | 48.03M |
| Entrada Therapeutics, Inc. | 335.52M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 98.93M |
| Shareholders Equity (Quarterly) | 11.62M |
| Debt to Equity Ratio | 5.669 |
| Current Ratio | 3.929 |
| Net Debt Paydown Yield | 2.17% |